BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7629228)

  • 1. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo.
    Lau KH; Nakade O; Barr B; Taylor AK; Houchin K; Baylink DJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2347-53. PubMed ID: 7629228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro.
    Nakade O; Baylink DJ; Lau KH
    J Dent Res; 1995 Jan; 74(1):331-7. PubMed ID: 7876426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats.
    Ohta T; Wergedal JE; Matsuyama T; Baylink DJ; Lau KH
    Calcif Tissue Int; 1995 May; 56(5):390-7. PubMed ID: 7621347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells.
    Takada J; Baylink DJ; Lau KH
    J Bone Miner Res; 1995 Oct; 10(10):1512-22. PubMed ID: 8686507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.
    Lau KH; Yoo A; Wang SP
    Mol Cell Biochem; 1991 Jul; 105(2):93-105. PubMed ID: 1922012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells.
    Schwartz Z; Carnes DL; Pulliam R; Lohmann CH; Sylvia VL; Liu Y; Dean DD; Cochran DL; Boyan BD
    J Periodontol; 2000 Aug; 71(8):1287-96. PubMed ID: 10972644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1.
    Nakade O; Baylink DJ; Lau KH
    J Bone Miner Res; 1996 Dec; 11(12):1880-8. PubMed ID: 8970889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells.
    Yoon HK; Baylink DJ; Lau KH
    Am J Nephrol; 2000; 20(2):153-62. PubMed ID: 10773618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
    Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
    J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.
    Lee WY; Cho SW; Oh ES; Oh KW; Lee JM; Yoon KH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2002 Jan; 87(1):329-35. PubMed ID: 11788670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro.
    Nakade O; Koyama H; Ariji H; Yajima A; Kaku T
    J Pineal Res; 1999 Sep; 27(2):106-10. PubMed ID: 10496146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
    de Pollak C; Arnaud E; Renier D; Marie PJ
    J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture.
    Ikedo D; Ohishi K; Yamauchi N; Kataoka M; Kido J; Nagata T
    Bone; 1999 Dec; 25(6):653-60. PubMed ID: 10593409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.
    Richman C; Baylink DJ; Lang K; Dony C; Mohan S
    Endocrinology; 1999 Oct; 140(10):4699-705. PubMed ID: 10499528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
    Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.